These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29622177)

  • 21. Radiopharmaceutical space.
    Eckelman WC; Kilbourn MR; Mathis CA
    Nucl Med Biol; 2006 Oct; 33(7):829. PubMed ID: 17045161
    [No Abstract]   [Full Text] [Related]  

  • 22. Paediatric diagnostic reference levels in nuclear medicine imaging in Ireland.
    Gray L; Torreggiani W; O'Reilly G
    Br J Radiol; 2008 Nov; 81(971):918-9. PubMed ID: 18941051
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined guide to NRC compliance now available.
    J Nucl Med; 2004 Jun; 45(6):28N. PubMed ID: 15181116
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.
    Yoshinaga K; Tamaki N
    J Nucl Cardiol; 2015 Aug; 22(4):690-9. PubMed ID: 25896679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.
    Gelfand MJ; Parisi MT; Treves ST;
    J Nucl Med; 2011 Feb; 52(2):318-22. PubMed ID: 21233182
    [No Abstract]   [Full Text] [Related]  

  • 26. [Survey questionnaire of pediatric nuclear medicine examinations in 14 Japanese institutes].
    Karasawa K; Kamiyama H; Hashimoto T; Koizumi K
    Kaku Igaku; 2013 May; 50(2):61-7. PubMed ID: 23855248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exemption of radiopharmaceuticals from <797>.
    Hung JC; VanBrocklin HF
    J Nucl Med; 2004 Oct; 45(10):14N. PubMed ID: 15551510
    [No Abstract]   [Full Text] [Related]  

  • 28. Status and plans for implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
    Mauer A
    J Nucl Med Technol; 2007 Jun; 35(2):112-3. PubMed ID: 17537736
    [No Abstract]   [Full Text] [Related]  

  • 29. Russian practical guidance on radiological support for justification of X-ray and nuclear medicine examinations.
    Balonov M; Golikov V; Kalnitsky S; Zvonova I; Chipiga L; Sarycheva S; Shatskiy I; Vodovatov A
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):39-42. PubMed ID: 25862538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health concerns related to radiation exposure of the female nuclear medicine patient.
    Stabin MG
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1403-9. PubMed ID: 9467052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
    Hung JC;
    J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
    [No Abstract]   [Full Text] [Related]  

  • 32. Assurance of the traceability chain for 131I measurement.
    Sahagia M; Razdolescu AC; Ivan C; Luca A
    Appl Radiat Isot; 2008 Apr; 66(4):539-44. PubMed ID: 18086529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.
    Lassmann M; Treves ST;
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1036-41. PubMed ID: 24599377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Practices in Myocardial Perfusion Scintigraphy in Brazil and Adherence to the IAEA Recommendations: Results of a Cross-Sectional Study.
    Rodrigues CVB; Oliveira A; Wiefels CC; Leão MS; Mesquita CT
    Arq Bras Cardiol; 2018 Feb; 110(2):175-180. PubMed ID: 29561994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiological Justification for and Optimization of Nuclear Medicine Practices in Korea.
    Kim BI
    J Korean Med Sci; 2016 Feb; 31 Suppl 1(Suppl 1):S59-68. PubMed ID: 26908990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee.
    Nucl Med Commun; 2000 Jan; 21 Suppl():S1-93. PubMed ID: 10732169
    [No Abstract]   [Full Text] [Related]  

  • 38. [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
    Barthel H; Meyer PT; Drzezga A; Bartenstein P; Boecker H; Brust P; Buchert R; Coenen HH; la Fougère C; Gründer G; Grünwald F; Krause BJ; Kuwert T; Schreckenberger M; Tatsch K; Langen KJ; Sabri O
    Nuklearmedizin; 2016 Aug; 55(4):129-37. PubMed ID: 27080914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applying Image Gently SM and Image Wisely SM in nuclear medicine.
    Jafari ME; Daus AM
    Health Phys; 2013 Feb; 104(2 Suppl 1):S31-6. PubMed ID: 23287517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Medical Imaging & Technology Alliance conference on research endpoints appropriate for medicare coverage of new PET radiopharmaceuticals.
    Hillman BJ; Frank RA; Abraham BC
    J Am Coll Radiol; 2013 Sep; 10(9):689-94. PubMed ID: 23916799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.